The University of Texas Health Science Center at Houston TX
Houston, Texas 77030
We've found
1 trials
at this facility
Muscle-invasive Transitional Cell Carcinoma of the Bladder Clinical Trial
Updated: 3/29/2016
Study of Intratumoral REOLYSIN® in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy in Muscle-invasive Transitional Cell Carcinoma of the Bladder
Status: Upcoming,
Phase
I
Updated: 3/29/2016
Click here to add this to my saved trials